ADS:
One of the most formidable and frequent complications of chronic pathology of the prostate gland is stones in the prostate. Approximately 8-10 years after the onset of the disease, 40% of men can detect the formation of calculi in the gland.
Prostate stones can be organic or inorganic. They are dense, located in the acini and ducts of the gland. The percentage of patients with prostate stones increases strongly with age. So at the age of 35, calculi occur in about 10% of cases, and by the age of 50, 80% of patients with prostatitis have these foreign bodies in the prostate gland.
This is a stagnation of the secretion of a glandular organ, its infection. Stagnation, in turn, is provoked by blockage of the ducts during inflammation and an increase in the size of the organ.
This theory was formed after a detailed crystallographic analysis of stones in the prostate, when it was noticed that most of the stones are composed of urine salts.
Despite this, it is still worth considering that amyloid bodies (the result of the formation of prostatic secretion) serve as the nucleus for the formation of calculi, around which urine salts are already deposited.
Stones are dangerous due to their location (acini and ducts), as they can clog them and lead to injury to soft tissues, disruption of blood circulation in the organ. In addition, stones support the inflammatory process, because they are a source of microorganisms.
All stones may differ in composition, be organic or inorganic. Their main components are: phosphate salts, uric acid salts, calcareous salts, oxalic acid salts, proteins, desquamated duct epithelium, prostate secretion.
Thus, the calculi are divided by composition into:
Stones are also divided according to the method of formation:
Specialists distinguish two more categories of prostatic calculi: true ones, which are formed in the gland, and false ones, which are brought from the urinary organs (kidneys, bladder) into the prostate with the flow of urine due to the resulting reflux.
When stones form in the prostate gland, typical symptoms occur, however, their intensity depends on the size of the stones, on how long the disease is, as well as the factors that cause them.
Nonspecific signs: weakness, fever to subfebrile numbers, chronic fatigue syndrome, decreased performance, headaches, changes in appetite, nausea.
Of the pathognomonic symptoms in the presence of stones in the prostate, the following should be mentioned:
High risk of getting complications in those patients who have stones in the gland:
The most reasonable solution when symptoms of the disease appear is to contact a specialist in a timely manner. Strict medical supervision and timely prevention of prostatitis and stone formation will help to avoid the disease or the development of its complications.
Doctor sexopathologist-andrologist of the 1st category. Work experience: 27 years
Alyaev Yu.G., Pshikhachev A.M., Shpot E.V., Akopyan G.N., Chinenov D.V. I.M
Introduction. The presence of a ureteral stone in patients with prostate cancer (PCa) poses a task for the surgeon to determine the nature and sequence of Surgical treatment of this category of patients.
The purpose of the study. To determine the tactics of treating patients with prostate cancer in combination with a ureteral stone.
Materials and methods. For the period from 2006 to 2015. In the clinic of urology, 1602 patients were operated on for prostate cancer, among which 54 (3.4%) patients had concomitant urolithiasis. In 36 (2.2%) patients from this group at the time of hospitalization there were indications for surgical treatment for both diseases. In 17 (47.2%) patients, the stone was located in the ureter.
Results. The leading clinical manifestations of ureteral stone were: in 9 (52.9%) patients - renal colic, in 4 (23.5%) - dull pain in the lumbar region, in 3 (17.6%) - acute obstructive pyelonephritis. In 1 patient, a ureteral stone was diagnosed by chance during examination for prostate cancer. In 15 (88.2%) patients, prostate cancer was localized, in the rest it was locally advanced. In the majority (94.1%) of patients, first of all, surgical treatment was performed aimed at getting rid of the ureteral stone. Only 1 patient with acute obstructive pyelonephritis caused by a stone in the upper third of the ureter underwent drainage of the upper urinary tract (UUT) with a stent catheter followed by radical prostatectomy (RP) due to a high risk of progression. In the postoperative period, 2 sessions of extracorporeal shock wave lithotripsy (ESWL) were performed with complete removal of stone fragments. For ureteral stones, the majority (82.4%) of patients underwent contact ureterolithotripsy (URL) or ESWL. 2 (28.6%) patients underwent percutaneous nephrolithotripsy due to large stones in the upper third of the ureter (in one case, the stone was previously displaced into the kidney during drainage of the upper urinary tract with a stent catheter for acute obstructive pyelonephritis).
Surgical treatment for prostate cancer in 53.0% of patients was performed in the volume of open, and in 23.5% - laparoscopic radical prostatectomy (RP). 4 (23.5%) patients underwent high-intensity focused ultrasound ablation of the prostate. Among the patients of this group there were also 2 patients with bilateral stones of the upper urinary tract. One patient with bilateral ureteral stones (without obstruction on one side) underwent successive ESWL sessions with complete removal of stone fragments, followed by open RP. The second patient with a ureteral stone on one side and a stone of the opposite kidney also successfully underwent ESWL sessions on both sides against the background of a catheter-stent on the side of the ureteral stone, followed by open RP at the second stage. In 2 patients with prostate cancer, in addition to ureteral stones, bladder stones were detected. One of them underwent laser cystolithotripsy and URSL at the first stage, then open RP. Another patient also underwent laser cystolithotripsy with simultaneous percutaneous ureterolithotripsy, and the second stage - open RP.
Conclusion.If a ureteral stone is detected in patients with prostate cancer, initially therapeutic measures should be aimed at ridding the patient of a ureteral stone, followed by surgical treatment of prostate cancer in the second stage. In the case of a high risk of progression of the tumor process and the expected long time for the patient to get rid of the ureteral stone, surgical treatment for prostate cancer should be carried out as the first stage against the background of drainage of the upper urinary tract.
Our advantages:
The most common urological disease - prostatitis has many causes and factors that provoke its exacerbation and progression. This and, already known to everyone from our previous publications, hypothermia, and sexual abstinence, and stagnation of blood in the vascular plexus of the small pelvis, sexually transmitted infections, alcohol and spicy food.
But there is another factor, or rather, a disease that has a multifaceted effect on the entire genitourinary system and on the prostate gland in particular. This is urolithiasis. Moreover, we are not necessarily talking about large stones in the pelvis, ureters or bladder. It can be microliths - small stones up to 0.3-0.5 cm, or just sand and high salt content in the urine.
Urologists often face problems in the treatment of chronic prostatitis, when even after adequate anti-inflammatory, antibacterial, local therapy in men, symptoms of inflammation of the prostate gland either remain or quickly return and the number of leukocytes in the prostate juice increases. Moreover, neither crops for flora, nor PCR reveal any pathogenic and opportunistic flora. And only ultrasound of the urinary system organs determines the presence of sand or stones.
There seem to be several factors involved:
Therefore, we strongly recommend that patients with prostatitis be carefully examined in more detail in terms of diagnosing KSD:
And, accordingly, if even minor signs of urolithiasis are detected, prescribe appropriate therapy that allows you to remove existing stones and relieve swelling and inflammation from the prostate gland, which also prevent the free exit of stones. That is, this treatment should simultaneously affect the KSD and chronic prostatitis.
Reception in our clinics daily from 9.00 to 21.00
In the South and South-Western Administrative Districts - metro Varshavskaya, Kakhovskaya, Sevastopolskaya - st. 8-499-317-29-7